Obesity and Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
SemBioSys achieves major milestone, reaches target levels of human insulin in safflower
August 14th, 2006
SemBioSys Genetics Inc. (SBS), a biotechnology company developing protein-based pharmaceuticals and nonpharmaceutical products, announced that the company has achieved its commercial target levels of human insulin (insulin) accumulation in safflower with 1.2% of total seed protein. The results from the company's commercial plant system exceeded its target of 1% accumulation and confirm the potential of plant-produced insulin to fundamentally transform the economics and scale of insulin production. SemBioSys intends to continue its preclinical program with safflower-derived insulin and assemble the components of its IND application including...
Source: Obesity and Diabetes Week (2006-08-14)
|
